News White House retreats from block on NIH research funding A move by the Trump administration to block NIH research funding for external research teams appears to have been abandoned.
News Pharma tariffs set to arrive with US-EU trade deal After some initial confusion, it has been confirmed that the 15% tariff rate on US imports from the EU will extend to pharmaceuticals.
News First details of Trump's most favoured nation plan emerge Donald Trump's plan to introduce a most favoured nation (MFN) system of drug pricing controls is not quite what he first said it would be.
News Call goes out for feedback on US health deregulation The Trump administration wants the public to join in the effort to cull redundant health regulations as part of its '10-for-one' deregulation policy.
News Update: Trump 'will tie US drug prices to other countries' President Donald Trump said he will sign an order today to cut prescription drug prices in the US to the level paid by other comparable countries.
News Pharma still in waiting mode after UK-US trade agreement Hopes that the UK-US trade agreement would give some clarity on the situation for pharmaceuticals proved optimistic.
News Remepy's hybrid Parkinson's therapy poised for phase 3 Remepy's Hybridopa therapy for Parkinson's, which combines an app with levodopa therapy, has shown efficacy in a phase 2 pilot study.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.